Humeral Head Posterior Subluxation on CT Scan: Validation and Comparison of 2 Methods of Measurement

2010 ◽  
Vol 11 (3) ◽  
pp. 72-76 ◽  
Author(s):  
Jacob F. Kidder ◽  
Dominique M. Rouleau ◽  
Juan Pons-Villanueva ◽  
Savvas Dynamidis ◽  
Michael J. DeFranco ◽  
...  
BMJ Open ◽  
2019 ◽  
Vol 9 (9) ◽  
pp. e032901 ◽  
Author(s):  
Christelle Pons ◽  
Dauphou Eddi ◽  
Gregoire Le Gal ◽  
Marc Garetier ◽  
Douraied Ben Salem ◽  
...  

IntroductionIn children with brachial plexus birth injury (BPBI), denervation of the shoulder muscles leads to bony deformity in the first months of life, reducing active and passive range of motion (ROM) and causing activity limitation. The aim of this multicentre randomised controlled trial is to evaluate the effectiveness of botulinum toxin injections (BTI) in the shoulder internal rotator muscles of 12-month-old babies in limiting the progression of posterior subluxation of the glenohumeral joint, compared with a sham procedure mimicking BTI. The secondary aims are to evaluate the effectiveness of BTI in (1) limiting the progression of glenoid retroversion and three-dimensional (3D) deformity and (2) improving shoulder ROM and upper limb function, as well as to confirm the tolerance of BTI.Methods and analysisSixty-two babies with unilateral BPBI and a risk of posterior humeral head subluxation will be included. Only those with at least 7% posterior subluxation of the humeral head compared with the contralateral shoulder on the MRI will be randomised to one of two groups: ‘BTI’ and ‘Sham’. The BTI group will receive BOTOX injections at the age of 12 months in the internal shoulder rotator muscles (8 UI/kg). The sham group will undergo a sham BTI procedure. Both groups will undergo repeated shoulder MRI at 18 months of age to quantify changes in the percentage of posterior migration of the humeral head (primary outcome), glenoid version and 3D bone deformity. Clinical evaluations (passive shoulder ROM, active movement scale) will be carried out at baseline and 15 and 18 months of age. The mini-assisting hand assessment will be rated between 10 and 11 months and at 18 months of age. Adverse events will be recorded at least monthly for each child.Ethics and disseminationFull ethical approval for this study has been obtained. The findings will be disseminated in peer-reviewed publications.Trial registration numberEudraCT: 2015-001402-34 in European Clinical Trial database;NCT03198702in Clinical Trial database; Pre-results.


2018 ◽  
Vol 27 (1) ◽  
pp. 181-188 ◽  
Author(s):  
Peter Domos ◽  
Caio Santos Checchia ◽  
Gilles Walch

2014 ◽  
Vol 37 (4) ◽  
pp. 357-361 ◽  
Author(s):  
Daphne Guenoun ◽  
Thomas Le Corroller ◽  
Aude Lagier ◽  
Vanessa Pauly ◽  
Pierre Champsaur

2008 ◽  
Vol 466 (3) ◽  
pp. 661-669 ◽  
Author(s):  
P. Boileau ◽  
R. T. Bicknell ◽  
N. Mazzoleni ◽  
G. Walch ◽  
J. P. Urien
Keyword(s):  
Ct Scan ◽  

2002 ◽  
Vol 11 (4) ◽  
pp. 309-314 ◽  
Author(s):  
Gilles Walch ◽  
Claudio Ascani ◽  
Aziz Boulahia ◽  
Laurent Nové-Josserand ◽  
T.Bradley Edwards

2019 ◽  
Vol 3 ◽  
pp. 247154921986578
Author(s):  
Siddhant K Mehta ◽  
Jay D Keener

The Walch B2 glenoid is characterized by a biconcave glenoid deformity, acquired glenoid retroversion, and posterior subluxation of the humeral head. Surgical reconstruction of the B2 glenoid is often challenging due to the complexity of the deformity. Bone graft augmentation using humeral head autograft is a valuable adjunct to anatomic total shoulder arthroplasty in the B2 glenoid, particularly in the young, highly active patient with severe glenoid retroversion (>25°–30°). Although this technique affords the ability to correct glenoid version and simultaneously enhances glenoid bone stock, it is technically challenging. The potential for graft-related complications also exists, which may further impact glenoid implant longevity and functional outcome. This review article aims to describe the B2 glenoid morphology, discuss the challenges in managing the B2 deformity, and provide further insight specifically regarding autografting at the time of anatomic total shoulder arthroplasty for reconstruction of the B2 glenoid.


Author(s):  
E. A. Belyak ◽  
A. P. Prizov ◽  
M. F. Lazko ◽  
I. V. Grigor’ev ◽  
N. V. Zagorodniy ◽  
...  

Treatment results for 7 patients who were operated on for neglected locked posterior subluxation of the humeral head with reverse Hill-Sachs lesion during 2013-2016 are presented. Surgical intervention included the open reduction of subluxation and transposition of thelesser tubercle of the humerusto a defect zone. Mean followup period was 14±3 months. Range of motion in shoulder joint and its function were restored almost completely with only small restriction in external rotation. No recurrence of subluxation was observed. All patients returned to professional and day-to-day activity. 


2017 ◽  
Vol 24 (3) ◽  
pp. 46-50
Author(s):  
Evgeniy A. Belyak ◽  
A. P Prizov ◽  
M. F Lazko ◽  
I. V Grigor’ev ◽  
N. V Zagorodniy ◽  
...  

Treatment results for 7 patients who were operated on for neglected locked posterior subluxation of the humeral head with reverse Hill-Sachs lesion during 2013-2016 are presented. Surgical intervention included the open reduction of subluxation and transposition of thelesser tubercle of the humerusto a defect zone. Mean followup period was 14±3 months. Range of motion in shoulder joint and its function were restored almost completely with only small restriction in external rotation. No recurrence of subluxation was observed. All patients returned to professional and day-to-day activity.


2019 ◽  
Vol 3 ◽  
pp. 247154921987035
Author(s):  
Lisa GM Friedman ◽  
Grant E Garrigues

The B2 glenoid is defined by Walch et al. as a glenoid that is biconcave with posterior erosion accompanied by posterior humeral head subluxation. This creates unique challenges for the treating orthopedic surgeon. Bone loss, excessive retroversion, and posterior subluxation make anatomic shoulder arthroplasty in this setting fraught with increased complications, including instability, glenoid component loosening, and poor clinical outcomes. Many techniques have been devised to treat the arthritic shoulder with a B2 glenoid, including hemiarthroplasty, total shoulder arthroplasty using eccentric reaming, bone grafting and custom implantation, and reverse total shoulder arthroplasty. In this review, we will focus on anatomic total shoulder arthroplasty using augmented glenoid implants to treat the B2 glenoid. Indications, clinical results, and basic science analyses of augmented anatomic glenoids are also discussed.


Sign in / Sign up

Export Citation Format

Share Document